{"id":3245,"date":"2012-11-08T12:30:00","date_gmt":"2012-11-08T12:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/"},"modified":"2012-11-08T12:30:00","modified_gmt":"2012-11-08T12:30:00","slug":"xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/","title":{"rendered":"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada."},"content":{"rendered":"<\/p>\n<p><span>The current main focus for XVIVO Perfusion is to gain marketing approval in North America for the company\u2019s unique product, STEEN Solution\u2122, which has the potential to increase the number of available organs for transplantation. XVIVO Perfusion has now gained marketing clearance from the Canadian regulatory authorities (Health Canada) for Steen Solution\u2122. Canada is an important market and Toronto General Hospital is one of the most important and active lung transplant centers in the world. It was there that the world\u2019s first successful clinical lung transplant was performed. <\/span><\/p>\n<\/p>\n<p><span>The company has an ongoing multicenter trial in the USA for STEEN Solution\u2122 and has submitted an application to the FDA to market it there. XVIVO Perfusion has previously obtained marketing approval for STEEN Solution\u2122 in the major markets outside North America.<\/span><\/p>\n<\/p>\n<p><span>November 8, 2012<\/span><span><\/span><\/p>\n<\/p>\n<p><span>Gothenburg<br \/><\/span><span>XVIVO Perfusion AB (publ)<br \/><\/span><span>Magnus Nilsson<br \/><\/span><span>CEO<\/span><\/p>\n<\/p>\n<div class=\"mfn-footer\">\n<p><span>FOR FURTHER INFORMATION, PLEASE CONTACT<br \/><\/span><br \/><span>Magnus Nilsson, CEO, tel: 46 31 788 21 50, e-mail: magnus.nilsson@xvivoperfusion.com<\/span><br \/><span>Christoffer Rosenblad, CFO, tel: 46 73 519 21 59, e-mail: <a href=\"mailto:christoffer.rosenblad@xvivoperfusion.com\" rel=\"nofollow\">christoffer.rosenblad@xvivoperfusion.com<\/a><\/span><br \/><span>For further information on Xvivo Perfusion\u2019s business, please refer to the company\u2019s website, <a href=\"http:\/\/www.xvivoperfusion.com\" rel=\"nofollow\">www.xvivoperfusion.com<\/a><\/span><\/p>\n<p><span>Xvivo Perfusion is required to publish the information in this press release in accordance with the Swedish Securities Market Act and\/or the Financial Instruments Trading Act. The information was submitted for publication on November 8, 2012 at 13:30 a.m.<\/span><\/p>\n<p><span>This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The current main focus for XVIVO Perfusion is to gain marketing approval in North America for the company\u2019s unique product,&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-3245","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-vpml","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada. - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada. - XVIVO\" \/>\n<meta property=\"og:description\" content=\"The current main focus for XVIVO Perfusion is to gain marketing approval in North America for the company\u2019s unique product,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\\\/\",\"name\":\"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada. - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2012-11-08T12:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada. - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/","og_locale":"en_US","og_type":"article","og_title":"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada. - XVIVO","og_description":"The current main focus for XVIVO Perfusion is to gain marketing approval in North America for the company\u2019s unique product,...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/","name":"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada. - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2012-11-08T12:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/xvivo-perfusion-receives-marketing-approval-for-steen-solution-in-canada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"XVIVO Perfusion receives marketing approval for STEEN Solution\u2122 in Canada."}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/3245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=3245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}